These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 21987061)

  • 21. Novel ion channel targets in atrial fibrillation.
    Hancox JC; James AF; Marrion NV; Zhang H; Thomas D
    Expert Opin Ther Targets; 2016 Aug; 20(8):947-58. PubMed ID: 26918581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of small-conductance calcium-activated potassium channels in atrial electrophysiology and fibrillation in the dog.
    Qi XY; Diness JG; Brundel BJ; Zhou XB; Naud P; Wu CT; Huang H; Harada M; Aflaki M; Dobrev D; Grunnet M; Nattel S
    Circulation; 2014 Jan; 129(4):430-40. PubMed ID: 24190961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition.
    Diness JG; Skibsbye L; Jespersen T; Bartels ED; Sørensen US; Hansen RS; Grunnet M
    Hypertension; 2011 Jun; 57(6):1129-35. PubMed ID: 21502564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic Effect of Either Negative Modulation or Blockade of Small Conductance Ca2+-activated K+ Channels on Ventricular Fibrillation in Guinea Pig Langendorff-perfused Heart.
    Diness JG; Kirchhoff JE; Sheykhzade M; Jespersen T; Grunnet M
    J Cardiovasc Pharmacol; 2015 Sep; 66(3):294-9. PubMed ID: 25978690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial selectivity of antiarrhythmic drugs.
    Ravens U; Poulet C; Wettwer E; Knaut M
    J Physiol; 2013 Sep; 591(17):4087-97. PubMed ID: 23732646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small-conductance Ca2+ -activated K+ channels and cardiac arrhythmias.
    Zhang XD; Lieu DK; Chiamvimonvat N
    Heart Rhythm; 2015 Aug; 12(8):1845-51. PubMed ID: 25956967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New pharmacological approaches to atrial fibrillation.
    Milnes JT; Madge DJ; Ford JW
    Drug Discov Today; 2012 Jul; 17(13-14):654-9. PubMed ID: 22370250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ionic determinants of atrial fibrillation and Ca2+ channel abnormalities : cause, consequence, or innocent bystander?
    Nattel S
    Circ Res; 1999 Sep; 85(5):473-6. PubMed ID: 10473677
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mechanically gated cardiac ion channels and their regulation by cytokines].
    Kamkin AG; Makarenko EIu
    Usp Fiziol Nauk; 2012; 43(4):3-44. PubMed ID: 23227720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential].
    Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1654-8. PubMed ID: 22875694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrical remodeling in atrial fibrillation.
    Dobrev D
    Herz; 2006 Apr; 31(2):108-12; quiz 142-3. PubMed ID: 16738832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel anti-arrhythmic agents for the treatment of atrial fibrillation.
    Wettwer E; Christ T; Dobrev D; Ravens U
    Curr Opin Pharmacol; 2007 Apr; 7(2):214-8. PubMed ID: 17303472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cardiac two-pore-domain K+ (K2P) channels--an emerging antiarrhythmic concept.
    Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D
    Eur J Pharmacol; 2014 Sep; 738():250-5. PubMed ID: 24927994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial fibrillation: Therapeutic potential of atrial K
    Ravens U; Odening KE
    Pharmacol Ther; 2017 Aug; 176():13-21. PubMed ID: 27742566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of potassium currents in cardiac arrhythmias.
    Ravens U; Cerbai E
    Europace; 2008 Oct; 10(10):1133-7. PubMed ID: 18653669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biology of the substrate of atrial fibrillation].
    Hatem S
    Biol Aujourdhui; 2012; 206(1):5-9. PubMed ID: 22463991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation.
    Pandit SV; Berenfeld O; Anumonwo JM; Zaritski RM; Kneller J; Nattel S; Jalife J
    Biophys J; 2005 Jun; 88(6):3806-21. PubMed ID: 15792974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium ion antagonists in supraventricular and ventricular arrhythmias.
    Schamroth L
    Cardiology; 1982; 69 Suppl():140-3. PubMed ID: 7151075
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat Atrium.
    Skibsbye L; Wang X; Axelsen LN; Bomholtz SH; Nielsen MS; Grunnet M; Bentzen BH; Jespersen T
    J Cardiovasc Pharmacol; 2015 Aug; 66(2):165-76. PubMed ID: 25856531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.